Get comparisons, analyses and forecasts for stocks, ETFs & funds
IBB vs IDNA
IBB is an ETF, whereas IDNA is a mutual fund. IBB has a lower expense ratio than IDNA (0.46% vs 0.47%). Below is the comparison between IBB and IDNA.
| IBB | IDNA | |
|---|---|---|
| Security Type | ETF | Mutual fund |
| Segment | Equity: U.S. Biotech | N/A |
| Issuer | BlackRock | iShares |
| Net Assets | $10.91B | $274.1M |
| Expense Ratio | 0.46% | 0.47% |
| Management Style | passive (index-based) | passive |
| Dividend Yield | 0.21% | 0.26% |
| Minimum Investment | N/A | N/A |
| YTD Return | 3.59% | 2.33% |
| 1-Year Return | 38.14% | 5.24% |
| 3-Year Return | 13.46% | N/A |
| 5-Year Return | 13.38% | N/A |
| 10-Year Return | 17.61% | N/A |
IBB description
The Fund seeks to track the investment results of the NASDAQ Biotechnology Index composed of biotechnology and pharmaceutical equities listed on the NASDAQ Stock Market. The Fund invests at least 90% of its assets in securities of the Underlying Index and in depositary receipts representing securities of the Index.
IBB performance & returns
| YTD Return | 3.59% |
| 1-Month Return | -2.31% |
| 3-Month Return | 8.29% |
| 1-Year Return | 38.14% |
| 3-Year Return | 13.46% |
| 5-Year Return | 13.38% |
| 10-Year Return | 17.61% |
IBB expense ratio is 0.46%.
IBB holdings
Top 10 Holdings (46.86% of Total Assets)
| Name | Symbol | % Assets |
|---|---|---|
| Gilead Sciences Inc | GILD | 7.48% |
| Amgen Inc | AMGN | 7.35% |
| Regeneron Pharmaceuticals Inc | REGN | 6.30% |
| Vertex Pharmaceuticals Inc | VRTX | 6.02% |
| Illumina Inc | ILMN | 4.74% |
| Biogen Inc | BIIB | 3.76% |
| Seagen Inc Ordinary Shares | SGEN | 3.26% |
| Moderna Inc | MRNA | 2.99% |
| Alexion Pharmaceuticals Inc | ALXN | 2.83% |
| Incyte Corp | INCY | 2.13% |
Other relevant IBB comparisons
You may also want to check out the following IBB comparisons that investors often look for on Finny
- IBB vs BBH
- IBB vs VHT
- IBB vs XBI
- IBB vs FBT
- IBB vs PBE
- IBB vs SBIO
- IBB vs BBC
- IBB vs CNCR
- IBB vs BBP
Or use Finny Compare Wizard to create a comparison you’d like to see.
IDNA description
The Fund seeks to track the investment results of NYSE FactSet Global Genomics and Immuno Biopharma Index. The Fund invests at least 90% of its assets in the components of the Index, which measures the performance of equity securities issued by companies in the biopharmaceutical and healthcare equipment and services.
IDNA performance & returns
| YTD Return | 2.33% |
| 1-Month Return | -6.63% |
| 3-Month Return | 5.24% |
| 1-Year Return | 5.24% |
| 3-Year Return | N/A |
| 5-Year Return | N/A |
| 10-Year Return | N/A |
IDNA expense ratio is 0.47%.
IDNA holdings
Top 10 Holdings (45.18% of Total Assets)
| Name | Symbol | % Assets |
|---|---|---|
| Mirati Therapeutics Inc | MRTX | 8.31% |
| Merck KGaA | MRK.DE | 4.62% |
| Invitae Corp | NVTA | 4.50% |
| Moderna Inc | MRNA | 4.31% |
| Genmab A/S | GMAB | 4.27% |
| Iovance Biotherapeutics Inc | IOVA | 4.22% |
| Seagen Inc Ordinary Shares | SGEN | 4.18% |
| CRISPR Therapeutics AG | CRSP | 3.89% |
| Kyowa Kirin Co Ltd | 4151 | 3.47% |
| Sarepta Therapeutics Inc | SRPT | 3.41% |
Other relevant IDNA comparisons
You may also want to check out the following IDNA comparisons that investors often look for on Finny
Or use Finny Compare Wizard to create a comparison you’d like to see.
You can check out all comparisons Finny users have looked for here. Feel free to the browse the list and view the comparisons that are of an interest to you.
